Transaction · 0001127602-25-002821

Dickinson Andrew D

Dickinson Andrew D, CFO, reported an open-market or private sale at GILEAD SCIENCES, INC. involving 142180.000000 shares for an estimated $13822739.60. Reported holdings after the transaction were 129873.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCFO
GILDGILEAD SCIENCES, INC.
Filing timeFeb 03
Trade dateJan 31, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

GILD price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
GILD since 2025-02-03Filed 577 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001127602-25-002821
Common Stock
Transaction date
Jan 31, 2025
Filed Feb 03, 2025, 11:09 PM · 3d delay
Shares
142k sh
$9.72k per share
Estimated value
-$1.38B
Computed from shares × price
Holdings after
129k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Reduction Large Sale Repeat Seller 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.

  2. F2

    Sales prices reported for the transactions reported here range from $97.22 to $97.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the…

  3. F3

    The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Original filing · 0001127602-25-002821
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

GILD